Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CRISPR Therapeutics AG(CRSP) | 1,048,951 | 2,038,763 | +989,812 | 51,021 | 132,132 | 19.11% | +81,111 |
| Zenas BioPharma, Inc(ZBIO) | 4,911,539 | 4,911,539 | 0 | 47,593 | 109,036 | 15.77% | +61,443 |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | 154,526 | 192,658 | 27.86% | +38,133 |
| Mineralys Therapeutics Inc.(MLYS) | 3,127,933 | 2,113,933 | -1,014,000 | 42,321 | 80,160 | 11.59% | +37,839 |
| Design Therapeutics, Inc.(DSGN) | 6,526,476 | 6,526,476 | 0 | 21,994 | 49,144 | 7.11% | +27,150 |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,514,929 | 4,514,929 | 0 | 45,827 | 54,179 | 7.84% | +8,353 |
| Oruka Therapeutics, Inc(ORKA) | 430,330 | 430,330 | 0 | 4,824 | 8,275 | 1.20% | +3,451 |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | 2,722 | 5,107 | 0.74% | +2,385 |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | 5,880 | 7,820 | 1.13% | +1,940 |
| Nkarta, Inc.(NKTX) | 3,333,333 | 3,333,333 | 0 | 5,533 | 6,900 | 1.00% | +1,367 |
| Oculis Holding AG(OCS) | 322,500 | 322,500 | 0 | 6,260 | 5,670 | 0.82% | -590 |
| KALA Bio, Inc.(KALA) | 598,940 | 0 | -598,940 | 2,851 | 0 | — | -2,851 |
| ARS Pharmaceuticals, Inc.(SPRY) | 4,012,903 | 4,012,903 | 0 | 70,025 | 40,330 | 5.83% | -29,695 |